Cite

HARVARD Citation

    Hamann, C. et al. (n.d.). Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus. Journal of bone and mineral research. pp. 627-638. [Online]. 
  
Back to record